Get the app
US › Healthcare

Carlsmed, Inc. (CARL)

US · Healthcare · Health Information Services

$15.39+0.52%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$18.9M
Revenue YoY
+56.7%
Net profit
$-10.5M
EPS
$-0.39
EPS estimate
$-0.40
Net margin
-55.5%

EPS came in at -0.39 against a street estimate of -0.40 — a beat of 2.5%.

Key statistics

Market cap
$402.2M
Forward P/E
0.0
P/B
4.78
Book value
$3.09
EPS (TTM)
$-2.34
52-week high
$17.23
52-week low
$8.50
50-day MA
$13.65
200-day MA
$12.20

Analyst view

with an average price target of $19.20.

Shareholding

Insiders
44.51%
Institutions
40.37%

Largest institutional holders

FundStake
Orbimed Advisors LLC4.59%
HHG PLC4.50%
Parkman Healthcare Partners LLC2.19%
BlackRock Inc1.64%
KCM Capital Inc1.61%
Pier Capital, LLC1.37%
Millennium Management LLC1.08%
Schonfeld Strategic Advisors LLC1.04%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Carlsmed, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.